Mission
CANCER RESEARCH AND TREATMENT FUND,INC.(CR&T) FUNDS RESEARCH EMPHASIZING THE CAUSE,PREVENTION,TREATMENT,AND CURE OF MYELOPROLIFERATIVE NEOPLASMS(MPNs)AND ALSOFUNDS OTHER BLOOD AND SOLID TUMOR CANCER RESEARCH.
Public Charity
CANCER RESEARCH AND TREATMENT FUND INC
CANCER RESEARCH AND TREATMENT FUND INC is a Public Charity headquartered in NEW YORK, NY. Financial data from the 2024 filing: $1.1M revenue, $1.0M expenses, $15.2M total assets. 31 publicly reported grants to this organization, totaling roughly $432K, appear in IRS filings.
EIN: 136272085
NEW YORK, NY
Latest filing: 2024
Total Revenue$1.1M
Total Expenses$1.0M
Total Assets$15.2M
Grant Records31
Funding Total$432K
Filing Years2020–2024
Sample Grants Received
UNRESTRICTED GENERAL SUPPORT
$30,000
For grant recipient's exempt purposes
$28,150
IN FURTHERANCE OF GRANTEE'S TAX-EXEMPT PURPOSE
$17,500
$9,800
$8,000
Showing up to 5 of 31 total records — full history available with membership.
Officers & Directors
Director
Adam Silver
Director
Aj Shiekman
Director
Amanda Johns Perez
Director
Anne Templeton
Director
Caleb Sexton
Director
David Boule
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1.1M | $1.0M | $15.2M |
| 2023 | $1.0M | $1.0M | $13.7M |
| 2022 | $573K | $957K | $12.6M |
| 2021 | $1.1M | $811K | $14.9M |
| 2020 | $1.4M | $809K | $14.0M |
Between 2020 and 2024, reported annual revenue declined from $1.4M to $1.1M (-19%), with total assets most recently reported at $15.2M.
Interactive year-over-year charts and full filing details available with membership.